{
  "paper_metadata": {
    "pmid": "39009827",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the BRCA2 variant T298I/V299L/V300R, including clinical significance, penetrance data, and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.892T>A, c.893C>T, c.894G>A",
      "protein_notation": "p.T298I/p.V299L/p.V300R",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "not specified",
          "evidence_sentence": "We cross-validated the fold-change in affinity for the binding of the MAP1LC3B ATG8 domain to wild-type/mutant (T298I/V299L/V300R) BRCA2292-307 peptide by isothermal titration calorimetry."
        }
      ],
      "functional_data": {
        "summary": "The binding effect of the BRCA2 variant was validated by isothermal titration calorimetry, confirming higher affinity for the mutant peptide.",
        "assays": [
          "isothermal titration calorimetry"
        ]
      },
      "segregation_data": "not specified",
      "population_frequency": "not specified",
      "evidence_level": "high",
      "source_location": "Table 1, Row 3",
      "additional_notes": "The variant was part of a study assessing the impact of mutations on protein interactions.",
      "key_quotes": [
        "We cross-validated the fold-change in affinity for the binding of the MAP1LC3B ATG8 domain to wild-type/mutant (T298I/V299L/V300R) BRCA2292-307 peptide by isothermal titration calorimetry."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Overview of affinity data.",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data was clear and specific to the BRCA2 variant."
  }
}